Q4 2020 Holdings
Filed 2021-02-16 | 78 holdings | $562.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $287.9M | 1,114,188 | 51.2% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $64.6M | 2,014,858 | 11.5% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $54.1M | 2,084,883 | 9.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $50.3M | 170,926 | 8.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $43.6M | 2,100,000 | 7.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $21.9M | 250,000 | 3.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $20.0M | 1,603,361 | 3.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $17.5M | 1,000,000 | 3.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $387.8K | 1,765,560 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $150.5K | 2,075,905 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $146.9K | 4,345,016 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $139.5K | 2,268,236 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $131.0K | 3,309,264 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $107.7K | 5,607,086 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $94.6K | 1,094,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $80.4K | 1,466,051 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $77.6K | 1,675,377 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $70.1K | 400,000 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $56.9K | 2,250,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $53.8K | 1,294,132 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $53.7K | 2,325,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $50.9K | 2,287,782 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $49.3K | 1,928,315 | 0.0% |
| Kinnate Biopharma Inc | COM | 49705R105 | $42.4K | 1,064,665 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $42.2K | 1,526,048 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $40.3K | 1,224,892 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $35.6K | 2,202,333 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $34.3K | 1,050,289 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $32.1K | 4,234,574 | 0.0% |
| Pandion Therapeutics Inc(PAND) | COM | 698340106 | $31.3K | 2,107,513 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $30.8K | 2,202,812 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $29.3K | 6,000,000 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $29.3K | 2,400,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $28.6K | 1,121,327 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $28.0K | 1,300,000 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $25.9K | 1,123,105 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $25.8K | 6,205,882 | 0.0% |
| Merus N V | COM | N5749R100 | $25.0K | 1,427,849 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $24.8K | 2,562,358 | 0.0% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $23.3K | 686,347 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $23.0K | 4,000,000 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $22.3K | 6,226,673 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $21.5K | 831,495 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $21.2K | 1,501,058 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $20.9K | 1,500,000 | 0.0% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $19.5K | 602,650 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $16.6K | 2,477,194 | 0.0% |
| Matinas Biopharma Hldgs Inc | COM | 576810105 | $15.6K | 11,478,634 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $13.7K | 1,251,055 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $13.0K | 7,534,598 | 0.0% |